Lindsey Rolfe

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Andrew Kucharchuk, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lindsey Rolfe:

Company Role Class Num Shares Value Price $ Report Date Ownership
CERO THERAPEUTICS HOLDINGS, INC. Director Stock Option (Right to Buy) 690,900 07 Jan 2026 Direct
Clovis Oncology, Inc. Officer Common Stock 113,691 02 Nov 2022 Direct
Clovis Oncology, Inc. Officer Restricted Stock Units 23,125 01 Nov 2022 Direct
Atreca, Inc. Director Stock Option (right to buy) 12,000 13 Jun 2023 Direct

Insider Reports Filed by Lindsey Rolfe

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CERO CERO THERAPEUTICS HOLDINGS, INC. 07 Jan 2026 1 $0 4 Director 09 Jan 2026, 16:30
CERO CERO THERAPEUTICS HOLDINGS, INC. 30 May 2025 1 $0 4 Director 02 Jun 2025, 17:06
CERO CERO THERAPEUTICS HOLDINGS, INC. 04 Mar 2025 1 $0 4 Director 06 Mar 2025, 16:16
CERO CERO THERAPEUTICS HOLDINGS, INC. 24 Feb 2025 1 $0 4 Director 26 Feb 2025, 18:06
CERO CERO THERAPEUTICS HOLDINGS, INC. 02 Dec 2024 1 $0 4 Director 04 Dec 2024, 21:12
CERO CERO THERAPEUTICS HOLDINGS, INC. 25 Mar 2024 1 $0 4 Director 27 Mar 2024, 21:29
CERO PHOENIX BIOTECH ACQUISITION CORP. 14 Feb 2024 0 $0 3 Director 16 Feb 2024, 19:29
/report/000120919123037521-rolfe-lindsey-2023-06-13 Atreca, Inc. 13 Jun 2023 1 $0 4 Director 15 Jun 2023, 18:10
/report/000089924322034890-rolfe-lindsey-2022-11-01 Clovis Oncology, Inc. 01 Nov 2022 6 -$4,188 4 Officer 03 Nov 2022, 16:15
/report/000089924322030421-rolfe-lindsey-2022-09-01 Clovis Oncology, Inc. 01 Sep 2022 3 -$3,054 4 Officer 06 Sep 2022, 16:15
/report/000089924322027577-rolfe-lindsey-2022-08-01 Clovis Oncology, Inc. 01 Aug 2022 6 -$6,326 4 Officer 03 Aug 2022, 16:15
/report/000120919122036101-rolfe-lindsey-2022-06-08 Atreca, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 18:42
/report/000089924322020946-rolfe-lindsey-2022-06-01 Clovis Oncology, Inc. 01 Jun 2022 3 -$1,703 4 Officer 03 Jun 2022, 16:15
/report/000089924322016295-rolfe-lindsey-2022-05-01 Clovis Oncology, Inc. 01 May 2022 6 -$8,376 4 Officer 03 May 2022, 16:15
/report/000089924322009062-rolfe-lindsey-2022-03-01 Clovis Oncology, Inc. 01 Mar 2022 7 -$20,423 4 Officer 03 Mar 2022, 15:15
/report/000089924322004583-rolfe-lindsey-2022-02-01 Clovis Oncology, Inc. 01 Feb 2022 6 -$8,756 4 Officer 03 Feb 2022, 15:17
/report/000089924321046772-rolfe-lindsey-2021-12-01 Clovis Oncology, Inc. 01 Dec 2021 3 -$1,038 4 Officer 03 Dec 2021, 15:16
/report/000089924321042707-rolfe-lindsey-2021-11-01 Clovis Oncology, Inc. 01 Nov 2021 6 -$19,151 4 Officer 03 Nov 2021, 16:18
/report/000089924321035113-rolfe-lindsey-2021-09-01 Clovis Oncology, Inc. 01 Sep 2021 3 -$1,697 4 Officer 03 Sep 2021, 16:15
/report/000089924321031440-rolfe-lindsey-2021-08-01 Clovis Oncology, Inc. 01 Aug 2021 6 -$20,220 4 Officer 03 Aug 2021, 21:32
/report/000120919121039839-rolfe-lindsey-2021-06-09 Atreca, Inc. 09 Jun 2021 1 $0 4 Director 11 Jun 2021, 16:31
/report/000089924321021857-rolfe-lindsey-2021-06-01 Clovis Oncology, Inc. 01 Jun 2021 3 -$1,813 4 Officer 03 Jun 2021, 19:00